We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWGL:NASDAQCL Workshop Group Limited Analysis

Data as of 2026-04-21 - not real-time

$0.91

Latest Price

8/10Risk

Risk Level: High

Executive Summary

The stock is trading just above its 20‑day simple moving average while remaining well below the 50‑day and 200‑day averages, a pattern that points to short‑term resilience amid a longer‑term downtrend. MACD has turned bullish with a positive histogram, and the RSI sits near the mid‑range at the low‑40s, suggesting limited upside momentum but no immediate oversold condition. Volume is on a decreasing trend, and the market exhibits exceptionally high 30‑day volatility, amplifying price swings.
Fundamentally, the company reports steep revenue contraction of over 30%, negative operating and profit margins, and a substantial debt load that dwarfs its cash reserves. The balance sheet shows a debt‑to‑equity ratio approaching 100%, and earnings per share are deeply negative, leaving little room for dividend sustainability. With a price‑to‑book modestly above 1.5 and a price‑to‑sales under 1, the equity appears cheap relative to its assets, yet the combination of weak cash flow, high leverage, and sector exposure to cyclical lumber demand heightens the risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish MACD crossover suggests possible near‑term price support
  • RSI near neutral limits immediate upside
  • Decreasing volume may constrain short‑term price gains

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained revenue decline and negative margins
  • High debt‑to‑equity ratio erodes financial flexibility
  • Bearish alignment of price below 50‑day and 200‑day SMAs

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Structural weakness in cash flow and profitability
  • Elevated volatility and beta indicate high market sensitivity
  • Limited upside from valuation metrics given fundamental distress

Key Metrics & Analysis

Financial Health

Revenue Growth-31.40%
Profit Margin-40.86%
ROE-68.65%
ROA-7.10%
Debt/Equity95.75
P/B Ratio1.6

Technical Analysis

TrendBearish
RSI44.8
Support$0.61
Resistance$1.09
MA 20$0.88
MA 50$1.07
MA 200$1.23
MACDBullish
VolumeDecreasing
Fear & Greed Index86.75

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.49
Volatility156.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.